Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Damora Therapeutics, Inc. (DMRA) Institutional Ownership & Insider Trading

104 institutions reported holding Damora Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DMRADamora Therapeutics, Inc.Follow DMRA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.3B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
30 Oct, in 6 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

104 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +16.2%.

Increased+25New+50Decreased-9Closed-12

Largest moves, shares (millions)

BlackRock+2.9MJPMorgan Chase+2.1MState Street+1.4MPoint72 Asset Management-1.1MBellevue Group AG-0.7MCormorant Asset Management-0.5M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-3.9Sep 24+0.0Dec 24+0.0Mar 25-0.0Jun 25+0.0Sep 25+0.8Dec 25+0.0Mar 26+8.7Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2610465+16.2%2550912
Mar 266556—————
Dec 25161+479.1%3936
Sep 25120—3431
Jun 2590-7.0%2042
Mar 25110+0.4%2312
Dec 24100—1222
Sep 2490-96.8%01714

Damora Therapeutics, Inc. — questions

Who owns Damora Therapeutics, Inc. stock?
104 institutions reported Damora Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (15.0%), Fairmount Funds Management LLC (14.1%), Avoro Capital Advisors LLC (6.1%).
Are Damora Therapeutics, Inc. insiders buying or selling?
2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Damora Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.